Cannabidiol Made in Morocco A New Era in Cannabis-Based Medicines

Saturday 21 December 2024 - 15:19

Morocco, a land rich in history and ancestral know-how, is making a significant stride in the global pharmaceutical landscape by tapping into the promising market of cannabis-based medicines. A Moroccan laboratory has recently garnered attention for launching the first-ever 100% locally produced cannabidiol (CBD) medication, marking a technological and scientific milestone.

CBD, a non-psychoactive compound extracted from cannabis, is known for its wide-ranging medical benefits. These include analgesic, anti-inflammatory, and anxiolytic properties, making it a valuable therapeutic option. The Moroccan laboratory has not only recognized the potential of CBD but has also successfully brought it to fruition.

This bold move is perfectly aligned with Morocco’s position as one of the world’s largest cannabis producers. By regulating the cultivation and legal use of the plant, the country is taking a decisive step toward integrating a green, ethical economy. Furthermore, this transition adds significant local value, transforming a controversial raw material into a highly therapeutic product, cannabidiol.

From Cannabis to Pharmaceutical Expertise

The pharmaceutical leader behind this innovation has ensured that the entire process, from cannabis cultivation in authorized regions like the Rif Mountains to the production of CBD in cutting-edge facilities, remains entirely local. This achievement places Morocco among a select group of nations capable of producing cannabis-based medicines that meet international standards.

This new CBD medication is designed to treat chronic pain and neurological conditions, with a focus on Moroccan patients who will benefit from a more affordable, locally-produced therapeutic solution. The medicine is expected to be available for commercial distribution by the first half of 2025, following approval in September 2024.

A key indication for the new treatment is drug-resistant epilepsy, a severe form of the condition that often doesn’t respond to conventional treatments. It is estimated that nearly 100,000 Moroccans, particularly children who suffer from daily seizures, will be able to access this groundbreaking treatment.

Bringing an Ancient Plant to Modern Medicine

Despite the clinical recognition of cannabidiol, the original, branded medication remains prohibitively expensive for many. By offering a generic version, Morocco aims to democratize access to this treatment, providing a high-quality, affordable alternative, particularly for patients from low- or middle-income households.

But Morocco’s ambition extends beyond its borders. By exporting this expertise, the country could quickly become a key player in the global cannabis-based medicine market, which is projected to be worth billions of dollars. This launch also represents a significant shift in Morocco's image, transforming the reputation of Moroccan cannabis from a symbol of illicit trade to one of innovation and contribution to public health.

The pioneering pharmaceutical laboratory is paving the way for a forward-looking industry that addresses the needs of citizens. CBD made in Morocco is not just a medicine—it is a promise for a future where the potential of Morocco’s land, combined with scientific innovation, improves the well-being of all.